Screen Shot 2017-06-27 at 3.17.45 PM.png

Rebecca Gibbs | President

Becca is a PhD student in the Biological and Biomedical Sciences program at Harvard. Her thesis work in the lab of Dr. Lee Rubin focuses on leveraging the regenerative potential of stem cells to develop novel treatments for muscle disorders.

LinkedIn

kellygirskis

Kelly Girskis | President

Director of the Harvard Biotech Incubator

Kelly is a PhD student in the Program of Neuroscience at Harvard. Her thesis work in Dr. Christopher Walsh's lab focuses on how evolutionary changes in the human genome contribute to species-specific gene regulation and corticogenesis.

LinkedIn

Emily Cohen | Vice President

Senior Director of Programming

Emily is a postdoc in the Pathology Department at Beth Israel Deaconess Medical Center. In the laboratory of Dr. Alex Toker, she is investigating the mechanism of resistance to therapeutic inhibitors in breast cancer.

LinkedIn

15776768_10155338936226416_8254825253733473024_o.jpg

Radwa Sharaf

Director of Site Visits

Radwa is a PhD candidate at Havard Medical School, working in the Infectious Diseases Division at Brigham and Women's Hospital. Her work focuses on mechanisms of HIV-1 control in a rare group of patients. In addition to bench work, she is interested in how host and pathogen sequences dictate phenotypes and cellular behavior. She also holds a a M.Sc in Molecular Medicine from Charité Medical School in Germany and a B.Pharm from Cairo University in Egypt.

LinkedIn

Ao_2017.JPG

Lin Ao

Director of Patent Law Course

Lin is a postdoctoral research fellow in the Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute. Her current work in the lab of Dr. Harvey Cantor focuses on the discovery of novel genetic targets in the tumor immune microenvironment. 

www.linkedin.com/in/linao5589

  Joseph Mandelbaum, Programming Team   Joseph is a PhD student in the Biological and Biomedical Sciences program at Harvard. His thesis work in the lab of Dr. Leonard Zon focuses on chemical screening for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures.         

Joseph Mandelbaum, Programming Team

Joseph is a PhD student in the Biological and Biomedical Sciences program at Harvard. His thesis work in the lab of Dr. Leonard Zon focuses on chemical screening for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures.

 

 

 

  Heather Landry, Programming Team   Heather Landry is a PhD student in the Genetics department at Harvard Medical School. The goal of her thesis research in Dr. Stirling Churchman’s lab is to better understand the molecular dynamics of transcription and splicing in human cells.

Heather Landry, Programming Team

Heather Landry is a PhD student in the Genetics department at Harvard Medical School. The goal of her thesis research in Dr. Stirling Churchman’s lab is to better understand the molecular dynamics of transcription and splicing in human cells.

  Fadi Najm, Programming Team   Fadi is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in the laboratory of Bradley Bernstein is centered on identifying and unraveling complex cancer dependencies. He holds an MBA from Case Western Reserve University and his previous patents and publications have recently resulted in the start-up of Convelo Therapeutics.   Linkedin

Fadi Najm, Programming Team

Fadi is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in the laboratory of Bradley Bernstein is centered on identifying and unraveling complex cancer dependencies. He holds an MBA from Case Western Reserve University and his previous patents and publications have recently resulted in the start-up of Convelo Therapeutics.  Linkedin

Screen Shot 2017-08-30 at 1.56.27 PM.png

Sofia Ribeiro Carlton

Director of Healthcare Innovation and Commercialization (HIC) Course

Sofia is a PhD student at Dana-Farber Cancer Institute and Harvard Medical School. Her thesis work focuses on the regulation of brain metabolism and its impact on neuronal excitability and seizure sensitivity. Sofia holds a B.Sc and M.Sc in Biochemistry from the University of Coimbra, Portugal. Sofia's strong interest on the life sciences industry was nurtured by taking the HIC course in 2013. She has helped organize HIC for 4 years.

 

IMG_3933.JPG

Andrew Ayoob

Director of Healthcare Innovation and Commercialization (HIC) Course

Andrew is a PhD student in the Harvard/MIT SHBT program, working on biomaterial drug delivery strategies to the inner ear.  He is conducting his thesis research at MIT under the direction of Professor Robert Langer and Dr. Jeffrey Borenstein of Draper Laboratory.  He serves as the treasurer and general partner of Irish Eagle Investment.               

DSC_7204.jpg

Daniel Selgrade

Director of Sponsorships

Daniel is a first year MMSc student in the Immunology Program at Harvard Medical School. His interests include systems biology, patent law, and translational medicine.                                                                                                                           

  Stephanie Fischinger, Programming Team    Stephanie is a PhD student from Germany working in the lab of Dr Galit Alter at the Ragon Institute of MGH, MIT and Harvard in Cambridge. Her research focuses on the effects of priming and boosting in HIV vaccine trials on antibody properties in order to dissect the optimal profile for a preventive HIV vaccine.

Stephanie Fischinger, Programming Team

Stephanie is a PhD student from Germany working in the lab of Dr Galit Alter at the Ragon Institute of MGH, MIT and Harvard in Cambridge. Her research focuses on the effects of priming and boosting in HIV vaccine trials on antibody properties in order to dissect the optimal profile for a preventive HIV vaccine.

IMG_4327.JPG

Hannah Goldberg

Healthcare Innovation and Commercialization (HIC) Course Logistics Coordinator

Hannah is a PhD student in the Harvard/MIT Speech Hearing Bioscience and Technology program. In 2016 she was accepted into Harvard's Therapeutics Graduate Program to further focus on pharmacology, toxicology and drug discovery. Her concentration in translational
science has brought her to the Holt/Géléoc Lab to explore the effectiveness of gene therapy as an approach to restore auditory functioning in models of human deafness. 

IMG_1437 2.JPG

Soufiane Aboulhouda

Director of Communications

Soufiane is a PhD student in the Biological and Biomedical Sciences program at Harvard. His thesis work in the lab of Dr. George Church focuses on the development of novel cell therapies, and application of genome editing technologies.                                                                              

  Ali Rudolph, Communications Team   Ali is a Ph.D student in the Biological and Biomedical Sciences program at Harvard University. She is a member of the team developing a strain of  Escherichia coli  with a 57-codon genome in George Church’s lab.

Ali Rudolph, Communications Team

Ali is a Ph.D student in the Biological and Biomedical Sciences program at Harvard University. She is a member of the team developing a strain of Escherichia coli with a 57-codon genome in George Church’s lab.